Evidence map›Paper›PMID 33216038›Full record

ArticleJournal of Alzheimer's disease : JAD2021

Association Between APOE Alleles and Change of Neuropsychological Tests in the Long Life Family Study.

Mengtian Du, Stacy L Andersen, Nicole Schupf, Mary F Feitosa, Megan S Barker, Thomas T Perls, Paola Sebastiani

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Causal mediation analysis of the neuroprotection ofmedRxiv : the preprint server for health sciences · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mengtian DuDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Stacy L AndersenGeriatrics Section, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Nicole SchupfDepartment of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, and the Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, NY, USA.
Mary F FeitosaDivision of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA.
Megan S BarkerDepartment of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, and the Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, NY, USA.
Thomas T PerlsGeriatrics Section, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Paola SebastianiInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.
Boston University · USColumbia University Irving Medical Center · USTufts Medical Center · US

Funding

The Long Life Family StudyU19AG063893 · NIA · WASHINGTON UNIVERSITY · PI Michael A. Province · 2019 to 2026
$125.4M
Systems BiologyU19AG023122 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI JODI A LAPIDUS · 2004 to 2026
$102.6M
Long Life Family Study: Data Management and Coordinating CenterU01AG023746 · NIA · WASHINGTON UNIVERSITY · PI PROVINCE, MICHAEL A. · 2004 to 2018
$29.2M
The Long Life Family StudyU01AG023755 · NIA · BOSTON MEDICAL CENTER · PI PERLS, THOMAS T · 2004 to 2018
$13.2M
Plasma beta-amyloid in long lived families: genetics and risk of ADU01AG023749 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI COSENTINO, STEPHANIE ANN, LEE, JOSEPH HYUNGWOO · 2004 to 2018
$13.0M
Multicenter Study on Exceptional Survival in Families: The Long Life Family StudyU01AG023744 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NEWMAN, ANNE B., ZMUDA, JOSEPH M. · 2004 to 2018
$12.0M
Long Life Family Study: Duke Univ./Univ. of Southern Denmark Field CenterU01AG023712 · NIA · DUKE UNIVERSITY · PI CHRISTENSEN, KAARE · 2004 to 2018
$10.4M
Integrative Omics to enhance therapeutics development for healthy agingUH3AG064706 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI MILLER, RICHARD A, SCHORK, NICHOLAS JOSEPH · 2021 to 2024
$3.3M
Protein Signatures of APOE2 and Cognitive AgingR01AG061844 · NIA · TUFTS MEDICAL CENTER · PI PERLS, THOMAS T, SEBASTIANI, PAOLA · 2018 to 2022
$3.1M
Digital Markers of Cognition Across the Spectrum of Preclinical Cognitive Impairment to DementiaK01AG057798 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ANDERSEN, STACY · 2018 to 2022
$596k
APOE alleles and extreme human longevityR21AG056630 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SEBASTIANI, PAOLA · 2017 to 2018
$488k
NIA NIH HHS K01 AG057798NIA NIH HHS R01 AG061844NIA NIH HHS R21 AG056630NIA NIH HHS U01 AG023712NIA NIH HHS U01 AG023744NIA NIH HHS U01 AG023746NIA NIH HHS U01 AG023749NIA NIH HHS U01 AG023755NIA NIH HHS U19 AG023122NIA NIH HHS U19 AG063893NIA NIH HHS UH3 AG064706
6 · The paper itself

Abstract

backgroundThe Long Life Family Study (LLFS) is a family based, prospective study of healthy aging and familial longevity. The study includes two assessments of cognitive function that were administered approximately 8 years apart.

objectiveTo test whether APOE genotype is associated with change of cognitive function in older adults.

methodsWe used Bayesian hierarchical models to test the association between APOE alleles and change of cognitive function. Six longitudinally collected neuropsychological test scores were modelled as a function of age at enrollment, follow-up time, gender, education, field center, birth cohort indicator (≤1935, or >1935), and the number of copies of ɛ2 or ɛ4 alleles.

resultsOut of 4,587 eligible participants, 2,064 were male (45.0%), and age at enrollment ranged from 25 to 110 years, with mean of 70.85 years (SD: 15.75). We detected a significant cross-sectional effect of the APOEɛ4 allele on Logical Memory. Participants carrying at least one copy of the ɛ4 allele had lower scores in both immediate (-0.31 points, 95% CI: -0.57, -0.05) and delayed (-0.37 points, 95% CI: -0.64, -0.10) recall comparing to non-ɛ4 allele carriers. We did not detect any significant longitudinal effect of the ɛ4 allele. There was no cross-sectional or longitudinal effect of the ɛ2 allele.

conclusionThe APOEɛ4 allele was identified as a risk factor for poorer episodic memory in older adults, while the APOEɛ2 allele was not significantly associated with any of the cognitive test scores.

Indexed as

AttentionCognitionCognitive AgingMemoryAdultAgedAged, 80 and overAge FactorsApolipoprotein E2Apolipoprotein E3Apolipoprotein E4Bayes TheoremFemaleHumansLongitudinal StudiesMaleApolipoprotein E2Apolipoprotein E3Apolipoprotein E4APOEcognitionlongevitylongitudinal studies

Identifiers

PMID33216038
PMCPMC7952213
OpenAlexW3103509914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.